Novo Nordisk A/S

Novo Nordisk (NYSE:NVO) has appealed to the U.S. Food and Drug Administration (FDA) to halt the production of compounded versions of its drugs Wegovy and Ozempic by compounding pharmacies. These cheaper alternatives have been under scrutiny due to potential safety risks and lack of FDA approval....

Editor’s Note: This story has been updated to include a statement from a Novo Nordisk spokesperson. Sen. Bernie Sanders (I-Vt.) has once again criticized Novo Nordisk A/S (NYSE:NVO) for the high price of its diabetes drug, Ozempic, in the United States. What Happened: On Sunday, Sanders took...

Major U.S. stock indices ended in the green on Wednesday, with the Nasdaq Composite marking notable gains of nearly 100 points. The Dow also ended Wednesday’s session in the green, while the S&P 500 experienced a slight uptick. The Nasdaq ended the day 96.83 points higher at 13,659.68,...

There has been some good news recently regarding diabetes, according to the Centers for Disease Control and Prevention. A new study published in the Journal of the American Medical Association indicated that after almost two decades of increase, the rate of diabetes in the United States may be...